BrilliantStrings is a mechanotherapeutics company with a focus on Complete Human Collagen(CHC™)
BrilliantStrings is one of only 4 companies to be recognized in the QuickFire Challenge. Focused on products that can benefit the elderly, BST's injectable CHC™ offers patients to heal tendon damage and recover lost mobility and strength.
See full AnnouncementOur science tells us that delivering Complete Collagen will improve outcomes!
Collagen molecules “home” to injury and with the proper application of force, will promote the healing process.
BrilliantStrings Team
CEO
Professor of Bioengineering
Northeastern University
Fellow AIMBE 2022
Board Chairwoman
Former CEO Rotation Medical
Former CEO Miach Orthopaedics
AdvaMed Board Member
Consultant Surgeon
Medical Director of Orthopaedic Sports Medicine, Rothman Orthopaedics FL & AdventHealth
Head Team Surgeon, Orlando Magic (NBA)
Chief Scientist
Lecturing Faculty
Mechanical Engineering
Harvard University
Chief Operations
Business Founder
Jackson Oakmont LLC
Author
Lincoln, MA - BrilliantStrings Therapeutics is developing transformative, direct protein therapies to accelerate the healing of soft connective tissues, is pleased to announce that we are one of 4 companies to be selected as an awardee in the Johnson & Johnson Innovation and The Johnson & Johnson Family of Companies in Japan Inaugural Smart Healthy Aging QuickFire Challenge. "This inaugural QuickFire challenge was designed to identify companies and technologies to aid in Japan's aging population. We are thrilled that the team at Johnson & Johnson Innovation and The Johnson & Johnson Family of Companies in Japan recognized the healing properties of CHC™ and the promise it brings to the elderly patient population" said Dr. Jeffrey Ruberti, CEO of BrilliantStrings. "Our injectable CHC™ product is focused on healing tissue damage too small for surgical repair."
Related Links:
Johnson & Johnson Innovation
CNET (Japanese)
Twitter
Learn more about our technology.
Copyright© BrilliantStrings Therapeutics 2022